MSB 2.70% 95.0¢ mesoblast limited

Hi WITH REGENERATIVE MEDICINE THE OUTCOMES OF PATIENTS WHO HAVE...

  1. 349 Posts.
    lightbulb Created with Sketch. 7
    Hi WITH REGENERATIVE MEDICINE THE OUTCOMES OF PATIENTS WHO HAVE RECEIVED STEM CELL TRANSPLANTS WILL NOT BE ALL THE SAME. BUT I THINK OUTCOMES IN RELATION TO INFLAMMAORTORY CONDITIONS WHICH IS A MAJOR SYMTOM FROM DESEASES CAN IMPROVE QUALITY OF LIFE FOR A LOT OF PEOPLE. JUST A LITTLE IMPROVEMENT WITH SOME OF THESE INFLAMMORTORY CONDITIONS CAN CHANGE PEOPLES LIFES.ALSO THE FACT THAT THIS IS A NATURAL PRODUCT AND NOT A STERIOD WHICH HAS TO BE INCREASED TO RECEIVE THE SAME BENEFIT AND ALSO DAMAGES THE IMMUNE SYSTEM.GOING FORWARD MESOBLAST WILL CERTAINLY HAVE PRODUCTS IN THE MARKET AS 1 PRODUCT ALREADY HAS APPROVAL IN CANADA AND NEW ZEALAND AND THEY ALSO HAVE A LICENSE IN AUSTRALIA FOR SOME SPECIFIC STEM CELL LINES.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
95.0¢
Change
0.025(2.70%)
Mkt cap ! $1.084B
Open High Low Value Volume
94.0¢ 96.8¢ 93.5¢ $4.207M 4.417M

Buyers (Bids)

No. Vol. Price($)
3 42268 94.0¢
 

Sellers (Offers)

Price($) Vol. No.
95.0¢ 48002 3
View Market Depth
Last trade - 16.10pm 09/08/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.